MedTrace Logo

Evolving Routine Standards in Intracoronary Physiology

NCT03082989 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1858

Last updated 2018-05-04

No results posted yet for this study

Summary

Italy is the European country with the minor penetration of FFR as compared to the number of percutaneous coronary intervention.

Accordingly, the Società Italiana di Cardiologia Invasiva (SICI-GISE) conceived and promoted a prospective nationwide study to describe the patterns of the use of FFR in an unselected real-world population and to to assess the reasons, on clinical decision making, driving operators in the use or not of the FFR.

Conditions

  • Myocardial Ischemia

Interventions

DEVICE

fractional flow reserve performed

assessing fractional flow reserve to drive revascularization

OTHER

fractional flow reserve not performed

description of the main reasons leading the operator to not use fractional flow reserve to drive the coronary revascularization

Sponsors & Collaborators

  • Società Italiana di Cardiologia Invasiva

    collaborator OTHER

  • University Hospital of Ferrara

    lead OTHER

Principal Investigators

  • Marco Luciano Rossi, MD · Humanitas, Rozzano (MI)

  • Giulio Stefanino, MD · Humanitas, Rozzano (MI)

  • Matteo Tebaldi, MD · AOU Ferrara

  • Gianluca Campo, MD · AOU Ferrara

  • Massimo Fineschi, MD · AOU Siena

  • Giuseppe Musumeci, MD · AOU Cuneo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-13
Primary Completion
2017-09-30
Completion
2017-10-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03082989 on ClinicalTrials.gov